Article abstract-The authors assessed clinical outcome for up to one year after staged bilateral pallidotomy in 14 patients with advanced PD. One year after surgery, dyskinesias were virtually abolished and there were significant reductions in "off" time (67%) and activities of daily living "off" scores (24%), as well as nonsignificant reduction in "off" motor score (39%); "on" scores were unchanged. One patient developed a visual field deficit; two had transient confusion. Staged bilateral pallidotomy improves motor function in selected patients with advanced PD.
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Clinical evaluations. For the preoperative baseline neurologic evaluations, patients were examined both in the "on" state and during the "practically defined off" state according to the Core Assessment Program for Intracerebral Transplantation (CAPIT) protocol using the Unified PD Rating Scale (UPDRS). 10 Dyskinesia measures were obtained in terms of intensity and duration; the intensity of dyskinesia scores was defined according to the CAPIT protocol but with a 0-to 4-point scale (0 ϭ none or unnoticed; 1 ϭ noticed but not bothersome; 2 ϭ interferes with some activities of daily living [ADL]; 3 ϭ interferes with most ADL; 4 ϭ incapacitating). A separate score was assigned to each limb including a score for trunk and neck (maximum score ϭ 24). Evaluations were performed at least every 6 months until 6 months after the second procedure. Data were available for 10 patients one year after the second surgery. For logistical reasons, it was not possible to obtain "practically defined off" data for all patients at each follow-up visit; hence the "off" motor score (UPDRS, Part III, items 18 to 31) is only available for a subset of patients (nine) who were examined in the "practically defined off" state at follow-up intervals. In all cases after the first pallidotomy, attempts were made to optimize the pharmacologic regimen in an effort to avert the need for a second surgical procedure.
Surgical procedure. Stereotactic PVP performed at our institution has been described previously. 2 Target selection was achieved using MRI and CT stereotactic localization and intraoperative macroelectrode stimulation.
Statistical analysis. In the case of the UPDRS, scores are presented as means of each subscale. Subcomponents of the UPDRS were analyzed using formulae as previously described. 1 All results were analyzed using the Wilcoxon signed rank test. The significance level was set at 0.05. Table 2 summarizes the results of UPDRS subscales, motor fluctuations, and dyskinesia scores expressed as means, standard deviations, and degrees of significance. There was no significant change in the mean levodopa-equivalent dosage during the follow-up period. Dyskinesias were virtually abolished after the staged bilateral PVP, and this improvement was maintained through the 6-month follow-up period (p Ͻ 0.01) and for one year in the 10 patients evaluated to that point (p Ͻ 0.05). There was a reduction in the number of hours spent in the "off" state (67%; p Ͻ 0.01 at one year). There was a corresponding increase in the percentage of the waking day spent in the "on" state, with patients spending 33% more of their day "on" than prior to the initial surgery (p ϭ 0.001). ADL "on" scores did not change throughout the follow-up period. ADL "off" scores were improved (30%; p Ͻ 0.01) at 6 months after the staged surgery, compared with baseline. The UPDRS Mentation and Behavior score was not significantly changed during the follow-up period.
Results.
The mean motor "on" scores did not change significantly compared with baseline during the follow-up period. The mean "off" motor score 6 months after the staged PVP was 36% improved compared with the prepallidotomy state, which was maintained at one year follow-up; this improvement was not significant. Tremor was improved both at 6 months ( p Ͻ 0.01) and at one year ( p Ͻ 0.05). There were no significant changes found in freezing spells, either in the "on" or "off" states during the follow-up period. Similarly, postural instability and gait disorder (PIGD) showed no significant changes during the follow-up period. Two patients experienced exacerbation of preoperative gait difficulties, principally with initiation of gait. There was no group effect of staged PVP on speech, ability to handle saliva, or swallowing, with the exception that "off" swallowing improved after the first operation. There was a nonsignificant deterioration in "on" speech found at 6 months compared with the preoperative value. One patient experienced persistent worsening of preexisting dysarthria, drooling, and dysphagia. Mild hypophonia was noted in five patients postoperatively. One patient developed a permanent quadrantanopia postoperatively caused by a delayed ischemic event. Two patients developed transient postoperative confusion lasting several days after the second surgery. There were no deaths and no intracerebral hemorrhages noted on postoperative MRI scans.
Discussion. We present 6-month follow-up results for 14 patients who underwent staged bilateral PVP for advanced PD, with one-year follow-up data for 10 patients. The results after unilateral pallidotomy in these patients are similar to those published in recent series. 1 The most dramatic result of the staged PVP was the near total abolition of levodopa-induced dyskinesias in all patients. A similar reduction was found in measurements of motor fluctuations, although most of this benefit was obtained after the unilateral procedure. Tremor was also improved significantly. There were few bulbar complications after the staged bilateral procedure in our series. As with unilateral PVP, bilateral PVP did not improve gait or postural instability.
Published reports regarding outcomes after staged bilateral PVP are relatively few, [4] [5] [6] [7] [8] [9] and interpretation of outcomes is hampered by inconsistencies in the use of standardized data collection and reporting. Table 3 summarizes the major published series of patients undergoing bilateral PVP since 1992. Our patients who underwent staged PVP were carefully selected on the basis of ongoing or progressive motor fluctuations and dyskinesias ipsilateral to the initial lesion; hence they are not representative of a consecutive group of patients with advanced PD. We believe that there is a role for staged bilateral PVP in such carefully selected patients. Although we found that staged bilateral PVP is associated with a higher incidence of adverse events, the widely held clinical impression that bilateral PVP leads to severe bulbar and cognitive dysfunction is not supported by our experience. 
